NCT00449670 Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults Status COMPLETED Phase PHASE3
NCT00448773 REDucing Influenza Among University Students, University of California at Berkeley Status COMPLETED Phase PHASE4
NCT00446628 Project to Investigate Ways to Reduce the Spread of Influenza in Schools and Households With Children Status COMPLETED Phase NA
NCT00442975 Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status Status COMPLETED Phase PHASE4
NCT00440362 A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza Status COMPLETED Phase PHASE1/PHASE2
NCT00436124 A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza. Status TERMINATED Phase PHASE4
NCT00436046 Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally Status COMPLETED Phase PHASE1
NCT00434733 Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects Status COMPLETED Phase PHASE3
NCT00430521 Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A) Status COMPLETED Phase PHASE2
NCT00425893 A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households Status COMPLETED Phase NA
NCT00424086 Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) Status COMPLETED Phase PHASE1/PHASE2
NCT00419263 Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. Status COMPLETED Phase PHASE2
NCT00417560 Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses Status WITHDRAWN Phase NA